DrugDev Acquires TrialNetworks as ‘Tech Glue’

DrugDev Acquires TrialNetworks as ‘Tech Glue’ 150 150 Biomedical & Health Informatics (BHI)

DrugDev announced this morning that it has acquired TrialNetworks. Financial terms were not disclosed, but the transaction was supported by investment from Invesco Perpetual.

TrialNetworks hosts what it calls the industry’s only cloud-based clinical trial optimization platform. TrialNetworks’ CEO Eric Silberstein says the company has been striving to improve clinical trial operations step by step, offering individual tools for each point in the workflow.

Read more on the link.